MEDINET Co., Ltd.
2370・Growth Market・Services
Governance
The company has a Board of Corporate Auditors. The Board of Directors consists of 7 members (3 outside directors and 4 internal directors), with outside directors accounting for approximately 43%. All 3 corporate auditors are outside auditors. The Board of Directors met 13 times during the fiscal year under review. No nomination committee or compensation committee has been established.
Risk Management
The company has established a Risk Management Committee chaired by the President and Representative Director, and conducts company-wide risk identification, assessment, and evaluation based on its Risk Management Regulations. In addition to developing an emergency response headquarters framework and a crisis communication manual, the company has entered into advisory agreements with multiple law firms to strengthen its management of strategic and legal risks.
Shareholder Returns
The company positions returning profits to shareholders as one of its most important priorities, but has no track record of dividend payments due to accumulated losses, and its policy is to prioritize securing internal reserves and investment in facilities and R&D.
Dividend Policy
No dividend track record. Due to accumulated losses, the policy is to first secure internal reserves to work toward the early elimination of accumulated losses, while prioritizing capital investment and R&D investment aimed at obtaining manufacturing and marketing approval for regenerative medicine products, as well as investment to acquire customers for the cell processing business. The basic policy is to pay dividends twice a year, an interim dividend and a year-end dividend, but at present the company continues to forgo dividends.
ESG
Sustainability promotion is reported and shared with the Board of Directors through the Compliance Committee and the Risk Management Committee. For human capital development, the company has introduced e-learning and conducted compliance training, and has established flexible working arrangements related to childcare and caregiving. The company has set a target for the paid leave utilization rate of 70.0% or higher by FY2026 (ending September 2026), with the actual rate as of the end of September 2025 standing at 67.9%.
Last updated: December 17, 2025